Edap Tms (NASDAQ:EDAP - Get Free Report) will likely be releasing its Q1 2025 earnings data before the market opens on Thursday, May 15th. Analysts expect the company to announce earnings of ($0.16) per share and revenue of $16.56 million for the quarter.
Edap Tms (NASDAQ:EDAP - Get Free Report) last posted its earnings results on Thursday, March 27th. The medical equipment provider reported ($0.05) EPS for the quarter, topping analysts' consensus estimates of ($0.11) by $0.06. Edap Tms had a negative net margin of 34.92% and a negative return on equity of 44.21%. The business had revenue of $22.69 million during the quarter, compared to the consensus estimate of $20.83 million. On average, analysts expect Edap Tms to post $-1 EPS for the current fiscal year and $0 EPS for the next fiscal year.
Edap Tms Stock Performance
Shares of NASDAQ:EDAP traded down $0.03 during trading on Tuesday, hitting $2.12. The company's stock had a trading volume of 5,845 shares, compared to its average volume of 96,621. The company has a 50-day moving average of $1.96 and a 200-day moving average of $2.27. The company has a debt-to-equity ratio of 0.08, a current ratio of 2.18 and a quick ratio of 1.46. Edap Tms has a 12 month low of $1.26 and a 12 month high of $7.11. The firm has a market cap of $78.66 million, a price-to-earnings ratio of -3.26 and a beta of 0.13.
Wall Street Analysts Forecast Growth
EDAP has been the subject of a number of recent analyst reports. Jefferies Financial Group reiterated a "hold" rating and issued a $2.00 price target (down from $8.00) on shares of Edap Tms in a research report on Friday, April 4th. StockNews.com started coverage on Edap Tms in a report on Wednesday, May 7th. They set a "hold" rating on the stock. HC Wainwright restated a "buy" rating and issued a $19.00 price objective on shares of Edap Tms in a research report on Friday, March 28th. Finally, Piper Sandler cut their target price on Edap Tms from $5.00 to $4.50 and set an "overweight" rating for the company in a research report on Friday, March 28th.
Check Out Our Latest Stock Report on EDAP
Edap Tms Company Profile
(
Get Free Report)
EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.
Recommended Stories

Before you consider Edap Tms, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Edap Tms wasn't on the list.
While Edap Tms currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.